Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning
- 1 December 2007
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 88 (2) , 179-187
- https://doi.org/10.1016/j.pbb.2007.08.004
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- β2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioningNeurobiology of Learning and Memory, 2008
- Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuliProceedings of the National Academy of Sciences, 2007
- Atomoxetine Reverses Nicotine Withdrawal-Associated Deficits in Contextual Fear ConditioningNeuropsychopharmacology, 2007
- Tolerance does not develop to the decrease in nicotine self‐administration produced by repeated bupropion administrationNicotine & Tobacco Research, 2005
- Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the MouseThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in ratsSynapse, 2003
- Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task.Behavioral Neuroscience, 1997
- Nicotine delivery kinetics and abuse liability.Journal of Consulting and Clinical Psychology, 1993
- Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.Behavioral Neuroscience, 1992
- Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.Behavioral Neuroscience, 1992